Pune: A total of 42 people have been found to be linked to Kovid-19. mucositis (CAM) in Pune district last week, taking the total number of cases, in the last three months, up to 1,238.
Officials said the number of new cases was declining. In May, 421 cases of CAM were registered in the district. 375 new cases were reported in June.
Of the 1,238 cases, 607 patients have fully recovered from the invasive fungal infection that primarily attacks the sinuses. A total of 459 patients are being treated in various hospitals of the district.
“We were reporting an average of 120 new CAM cases every week in the last two months. The weekly numbers have now seen a huge drop along with a huge drop COVID-19 cases,” said a senior health official.
A total of 172 of the 1,238 patients succumbed, accounting for a 13% mortality rate, which experts said is well below the reported mortality rate – (from a minimum of 30% to a maximum of 50%) that occurred in pre-Covid mucormycosis patients. was spotted.
Experts said swift efforts by doctors and rational use of available anti-mucormycosis drugs such as posaconazole and isovuconazole had managed to keep the mortality rate under control despite a nationwide shortage of critical drugs like amphotericin B.
However, health workers said CAM-related deaths were more likely as many patients were unable to continue treatment in hospital due to exorbitant costs and could not report their deaths at home. He said only long-term follow-up would be able to determine the true toll.
“Covid-associated mucormycosis is very different from mucormycosis” pre-covid,” said ENT surgeon Ashish Bhumkar, who is on the state CAM task force. He added, “In post-Covid mucormycosis, the patient is immunocompromised and fights the fungus very hard. A large number of patients are young and they are doing better. In addition, diagnosis is made very early and treatment is started early.”
Officials said the number of new cases was declining. In May, 421 cases of CAM were registered in the district. 375 new cases were reported in June.
Of the 1,238 cases, 607 patients have fully recovered from the invasive fungal infection that primarily attacks the sinuses. A total of 459 patients are being treated in various hospitals of the district.
“We were reporting an average of 120 new CAM cases every week in the last two months. The weekly numbers have now seen a huge drop along with a huge drop COVID-19 cases,” said a senior health official.
A total of 172 of the 1,238 patients succumbed, accounting for a 13% mortality rate, which experts said is well below the reported mortality rate – (from a minimum of 30% to a maximum of 50%) that occurred in pre-Covid mucormycosis patients. was spotted.
Experts said swift efforts by doctors and rational use of available anti-mucormycosis drugs such as posaconazole and isovuconazole had managed to keep the mortality rate under control despite a nationwide shortage of critical drugs like amphotericin B.
However, health workers said CAM-related deaths were more likely as many patients were unable to continue treatment in hospital due to exorbitant costs and could not report their deaths at home. He said only long-term follow-up would be able to determine the true toll.
“Covid-associated mucormycosis is very different from mucormycosis” pre-covid,” said ENT surgeon Ashish Bhumkar, who is on the state CAM task force. He added, “In post-Covid mucormycosis, the patient is immunocompromised and fights the fungus very hard. A large number of patients are young and they are doing better. In addition, diagnosis is made very early and treatment is started early.”
.